Financials
- Financial year
- 2025
- Total assets
- €623,225
- Profit
- €16,432
- Solvency
- 10.9%
Total assets▲ 0.8%
Net result
20192025
IMMOGYN
ActiveSummary
IMMOGYN has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,892 and a net result of €16,432. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 30% of 11,189 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Renting and operating of own or leased non-residential real estate, excluding land
NACE 68203
1 site
Size
€623,225total assets 2025
- Equity
- €67,892
- Profit
- €16,432
Structure
- Largest shareholder
- GynécoPP · 14.29%
- Board
- 6 members
2025 accounts 24 days early1 of 3 deeds summarised
Why 90raises riskEquity €67,892 (10.9% of total assets)lowers riskSize: total assets €623,225Sector: Real estate activities (NACE 68)Figures for financial year 2025 (filed 07-07-2026)Show the evidence
Checked score
Score 2025
90
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 55% of its sector peers (NACE 68, micro)
Financial strength · tick = 2024
Average
Solvency
36+3
equity 10.9% of total assets
Liquidity
48+1
short-term debt 19.4% · cash 3.4%
Profitability
72=
return on assets 2.6%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.4%
12-2024: 0.4%● unchanged vs 11-2024
01-2025: 0.4%● unchanged vs 12-2024
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.5%▲ +0.1 percentage points vs 02-2025
04-2025: 0.5%● unchanged vs 03-2025
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025highest value
08-2025: 0.2%▼ -0.3 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.3%▲ +0.1 percentage points vs 06-2026
08-2026: 0.2%▼ -0.1 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.24, compared with 0.19 in 2024, below 1; short-term debt: 19.4% and cash: 3.4% of total assets), and 89.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro): better than 32% on solvency, 45% on liquidity, 63% on profitability and 81% on growth.
The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
24 days early
2024
31 days early
2023
on the day
2022
22 days late
2021
24 days late
2020
11 days early
2019
2 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 68) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · full…
- Highest result from 2019 to 2025net €16,656 ▲14.3%
Key points
By topic
Board & ownership
- Board
- 6 members
- Largest shareholder
- GynécoPP · 14.29%
- GynécoPPDirector
- DOUPAGNE AlixDirector
- HANOCQ FlorenceDirector
- JOHNSON StéphanieDirector
- MERINDOL CélineDirector
and 1 other director
Timeline
- Events
- 11
- Since
- 2020
- Next accounts
- by 31-07-2027
- 31-07-2024Annual accounts filed
- 25-10-2023Resignation: KRIDELKA Frédéric Jean Léon Alex (director)
- 22-08-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Renting and operating of own or leased non-residential…NACE 68203
- Founded
- 01-03-2019
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 37
- Annual meeting
- Last Monday of June at 18:00
Key facts about IMMOGYN
- What is the company number of IMMOGYN?
- 0721.754.333. In Belgium the VAT number is the company number with BE in front: BE 0721.754.333.
- Where is IMMOGYN based?
- The registered office is at Au long pré 65, 4053 Chaudfontaine.Company details
- What does IMMOGYN do?
- According to the KBO register, the main activity is renting and operating of own or leased non-residential real estate, excluding land (NACE 68203).
- What is the legal form of IMMOGYN?
- Private limited company (BV).
- When was IMMOGYN founded?
- On 01-03-2019.
- Is IMMOGYN still active?
- Yes, IMMOGYN is an active enterprise in the KBO register.
- What is the turnover of IMMOGYN?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is IMMOGYN profitable?
- In financial year 2025, IMMOGYN made a profit of €16,432.
- Where can I find the annual accounts of IMMOGYN?
- IMMOGYN filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of IMMOGYN due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to IMMOGYN
Shareholders
- GynécoPP14.29%
Comparable companies
- J.C.D.C.Gembloux
- R.O.B.Ranst
- FoltadelBrussel
- VAN HOVE TRUCK CENTER ANTWERPENLier
- BDS AG IMMOManage
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.